Novavax, Inc. (NASDAQ:NVAX)

Ebola Virus

Does Novavax Have the Answer for Ebola in New Trial?

Last fall a huge driver of biotech companies was the outbreak of Ebola and the fear associated with this deadly disease. The reality is that this disease is still a ...
Read Full Story »
Sell Button

Large Media Trade Highlights Recent Insider Selling

In a week that saw big up and down swings, there weren't really many insiders lining up to sell stock. That is a change from what we saw over the ...
Read Full Story »
95992888

Russell Rebalancing Will Bring Massive Buy Orders for 5 Key Stocks

With April coming to a close on Thursday, it is time for yet another rebalancing of some of the biggest indexes on Wall Street. At the close on Thursday, the ...
Read Full Story »
ten dollars

7 Analyst Stocks Under $10 With Massive Upside Calls

The first full week of April saw the S&P 500 hit 2,100 again and also saw the Dow hit 18,000 again. Investors keep looking for value where they can find ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: AmEx, BIND, Devon, GM, Novavax, Teck and More

Stocks have recovered slightly on Tuesday morning. One trend that has held steady is that investors keep buying their favorite stocks every time the market sells off. 24/7 Wall St. ...
Read Full Story »
ten dollar bills

8 Analyst Stocks Under $10 With Huge Upside Targets

The last full week of March was choppy and took away most of the 2015 gains for the Dow and the S&P. Still, investors keep looking for value, and the ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Cisco, EMC, GameStop, Novavax, Tesla, Yahoo and More

Stocks were looking for direction on Friday morning after a choppy week. The one thing we have seen for about three years now is that investors have lined up in ...
Read Full Story »
Monkey evil

Top Analyst Upgrades and Downgrades: Crocs, Halliburton, Nuance, Staples, Yelp and More

Stocks were taking a steady breather going into the unemployment report after two major rallies in a row this week. What stands out is that investors keep proving that they will ...
Read Full Story »
ten dollar bills

13 Analyst Stocks Under $10 With Major Upside Calls

Volatility has returned in a major way in the stock market, and investors saw the single worst day of 2014 on Thursday, October 9. What we are continuing to see ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Apple, Alcobra, Deere, GT, J.C. Penney and More

Stocks were weak on Tuesday, but investors keep proving that they will aggressively buy overlooked or oversold stocks when they can. 24/7 Wall St. reviews dozens of brokerage firm analyst ...
Read Full Story »
uncertainty market evolution

ETF Rebalance Could Make 5 Biotech Stocks Shoot Higher

When indices like the S&P 500 or the Russell 2000 rebalance at the end of quarters, there is often high volatility in stocks that need to be bought or sold, ...
Read Full Story »
ten dollars

10 Analyst Stocks to Buy Under $10 With Massive Upside Calls

Stocks had a crazy end to the week on reports of tension escalation and fighting in Ukraine and Russia. Still, investors are looking to use market weakness to find bargain ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: FuelCell, JDSU, King, SunEdison, Google, Facebook and More

Stocks were well up on Wednesday morning. While volatility has returned to the stock market, it seems as though investors are looking to accumulate stocks that have sold off and ...
Read Full Story »
$5

Eight Biotech Stocks Trading Near $5 With Huge Upside Potential

Often when a strong sell-off hits the stock market, the first stocks to go are the big momentum stocks that hedge funds often chase for performance and alpha. Right behind ...
Read Full Story »
biotech

Biotech Stocks Under $10 With Huge Upside Potential for 2014

Large cap biotech stocks have seen incredible stock performance over the past few years. The problem for many investors is that many of the key stocks have become so expensive ...
Read Full Story »